{"entity":{"type":"insider","cik":"0001621172","url":"/insider/0001621172","json_url":"/insider/0001621172.json","name":"Mauro David J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":11,"first":"2015-10-22","last":"2021-10-06","span_basis":"filed_date"},"name_variants":[{"name":"Mauro David J","source":"filing","n_filings":11,"first_seen":"2015-10-22","last_seen":"2021-10-06"}],"transactions":[{"id":4236860,"accession":"0001209191-21-059850","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-059850","line_url":"/filing/0001209191-21-059850","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.95666066,"price_display":"30.96","price_state":"stated","total_value":464349.9099,"total_display":"464,349.91","total_whole":"464,350","shares_owned_after":1289.0,"shares_owned_after_display":"1,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-06","scope":"insider","n_lines":3},{"id":4732073,"accession":"0001209191-21-055307","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-055307","line_url":"/filing/0001209191-21-055307","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":36.685503106666665,"price_display":"36.69","price_state":"stated","total_value":550282.5466,"total_display":"550,282.55","total_whole":"550,283","shares_owned_after":7513.0,"shares_owned_after_display":"7,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider","n_lines":3},{"id":4426504,"accession":"0001209191-21-050404","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-050404","line_url":"/filing/0001209191-21-050404","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":31.092947833333334,"price_display":"31.09","price_state":"stated","total_value":466394.2175,"total_display":"466,394.22","total_whole":"466,394","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-09","scope":"insider","n_lines":4},{"id":5334923,"accession":"0001209191-21-046013","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-046013","line_url":"/filing/0001209191-21-046013","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":27.47380263333333,"price_display":"27.47","price_state":"stated","total_value":412107.0395,"total_display":"412,107.04","total_whole":"412,107","shares_owned_after":4555.0,"shares_owned_after_display":"4,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider","n_lines":3},{"id":4730099,"accession":"0001209191-21-039261","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-039261","line_url":"/filing/0001209191-21-039261","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.44149,"price_display":"32.44","price_state":"stated","total_value":486622.35,"total_display":"486,622.35","total_whole":"486,622","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":3},{"id":4997081,"accession":"0001209191-21-031248","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-031248","line_url":"/filing/0001209191-21-031248","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":40.1394597,"price_display":"40.14","price_state":"stated","total_value":602091.8955,"total_display":"602,091.90","total_whole":"602,092","shares_owned_after":1109.0,"shares_owned_after_display":"1,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-10","scope":"insider","n_lines":3},{"id":5099656,"accession":"0001209191-21-029033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-029033","line_url":"/filing/0001209191-21-029033","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":35.393914744,"price_display":"35.39","price_state":"stated","total_value":884847.8686,"total_display":"884,847.87","total_whole":"884,848","shares_owned_after":1711.0,"shares_owned_after_display":"1,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-29","scope":"insider","n_lines":3},{"id":4666849,"accession":"0001209191-21-027874","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-027874","line_url":"/filing/0001209191-21-027874","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.893972,"price_display":"30.89","price_state":"stated","total_value":772349.3,"total_display":"772,349.30","total_whole":"772,349","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider","n_lines":2},{"id":5158594,"accession":"0001209191-21-026872","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-026872","line_url":"/filing/0001209191-21-026872","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9617.0,"shares_display":"9,617","price_per_share":38.354193979411455,"price_display":"38.35","price_state":"stated","total_value":368852.2835,"total_display":"368,852.28","total_whole":"368,852","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-15","scope":"insider","n_lines":4},{"id":5042868,"accession":"0001209191-21-026291","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-026291","line_url":"/filing/0001209191-21-026291","is_derivative":false,"issuer_cik":"0001621172","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001621172","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15383.0,"shares_display":"15,383","price_per_share":39.33064229344081,"price_display":"39.33","price_state":"stated","total_value":605023.2704,"total_display":"605,023.27","total_whole":"605,023","shares_owned_after":7083.0,"shares_owned_after_display":"7,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-09","scope":"insider","n_lines":2},{"id":8777338,"accession":"0001493152-15-004951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-15-004951","line_url":"/filing/0001493152-15-004951#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001621172","owner_name":"Mauro David J","owner_display_name":"Mauro David J","owner_url":"/insider/0001621172","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24586.0,"shares_display":"24,586","price_per_share":10.08,"price_display":"10.08","price_state":"stated","total_value":247826.88,"total_display":"247,826.88","total_whole":"247,827","shares_owned_after":165932.0,"shares_owned_after_display":"165,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-20","filed_date":"2015-10-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001678660","name":"Prelude Therapeutics Inc","url":"/issuer/0001678660","role":"Officer (Chief Medical Officer)","n_filings":10,"first_seen":"2021-04-09","last_seen":"2021-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001100397","name":"Advaxis, Inc.","url":"/issuer/0001100397","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2015-10-22","last_seen":"2015-10-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001621172","retrieved_at":"2026-08-24T07:22:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}